Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2024 · research · Research Grant
Developing A Resource for Exploring the Molecular Markers of Parkinson’s Disease
Charlie Kim · Verily Life Sciences LLC (United States)
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program
Preclinical Testing of Novel DBS Protocol for Long-Lasting Therapeutic Effects
Aryn Gittis · Carnegie Mellon University
2024 · research · Research Grant
Qualitative Evaluation of Draft Questionnaires for Patient-reported Outcome Measures of Non-motor Symptoms in Early-stage Parkinson's Disease
Sonya Ludmilla Eremenco · Critical Path Institute
2024 · research · Research Grant
Assessment of Longitudinal Imaging Using Radiolabeled AV-133 in Early and Prodromal Parkinson’s Disease
Gilles D. Tamagnan · Xingimaging, A Mitro Company
2024 · research · Research Grant
Developing a Binding Assay to Detect Toxic Alpha-synuclein Aggregates in Cerebrospinal Fluid and Plasma
Valerie Daggett · University of Washington
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
First-in-human Phase 1a Study to Assess Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending doses of SB-0110 after Oral Administration in Healthy Subjects
Aarash Bordbar · Sinopia Biosciences (United States)
2024 · research · Research Grant
Quantification of Three Previously Identified Biomarkers of Progression in Stage 2/3 of Parkinson’s Disease
Brit Mollenhauer · Universitätsmedizin Göttingen
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
(SUPPLMENT) Evaluating the Neuroprotective Factor REST as a Target for Parkinson’s Disease
Nora Bengoa-Vergniory · Achucarro Basque Center for Neuroscience
2024 · research · ASAP CRN Competitive Renewal Opportunity
Parkinson5D: Deconstructing Disease Mechanisms Across Cells, Space and Progression
Clemens Scherzer · Yale University
2024 · research · Biomarkers to Support Therapeutic Trials Program
Using Detection of Apoptosing Retinal Cells to Predict Disease Activity in Parkinson’s Disease
Richard St. John Nicholas · Imperial College Healthcare NHS Trust
2024 · research · Therapeutic Pipeline Program
Integrin CLOAKs as Novel Oral Therapeutics for Parkinson’s Disease
Vineet Gupta · The University of Texas Medical Branch at Galveston
2024 · research · ASAP CRN Competitive Renewal Opportunity
Examining the Mechanisms of Mitochondrial Damage Control by PINK1 and Parkin
James H. Hurley · University of California, Berkeley
2024 · research · 2021 RFA: PIPETTE 4R Tau and Alpha-Synuclein PET Tracer Development
SUPPLEMENT: Rescreening of the MJFF Compound Library to Identify Molecules that Can be Used to Monitor Alpha-synuclein
Robert H. Mach · University of Pennsylvania
2024 · research · Edmond J. Safra Movement Disorders Research Career Development Award
Towards a Better Understanding of Treatment-refractory Gait Issues in Parkinson’s Disease
Kimberly Tsu Kwei · Columbia University
2024 · research · ASAP CRN Competitive Renewal Opportunity
Identifying Mechanisms that Overwhelm Protein and Organelle Quality Control in Parkinson’s Disease
J. Wade Harper · Harvard University
2024 · research · Research Grant
SUPPLEMENT: Development of a Protein Biomarker Panel to Measure Parkinson’s Disease Activity and Progression
James Langdon Eubanks · Octave Bioscience
2024 · research · ASAP CRN Competitive Renewal Opportunity
Studying the Cortical Pathophysiology of Parkinsonism
Thomas Wichmann · Emory University
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Targeting LRRK2 Dysfunction Using Aptamers in People with Parkinson’s Disease
Ganesh Iyer · Opprtna Therapeutics Inc
2024 · research · Research Grant
Developing Community Health Worker Remote Training Modules on Research, Brain Health and Parkinson’s Disease
Aaron Sylvan Lord · NYU Langone Health
2024 · research · Research Grant
Developing Outcome Measures for Assessing Freezing of Gait: A Multi-Center Study
Jeffrey M. Hausdorff · Tel Aviv Sourasky Medical Center
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Discovery of Translational Pharmacodynamic Biomarkers and Biomarkers of Endo-lysosomal Pathway Pathology by Biased & Unbiased Lipidomics and Metabolomics
Joanna Wolak · Endlyz Uk Limited
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Investigating the Effects of Pesticide Exposure on Immune System Function in Parkinson’s Disease
Kimberly Paul · University of California, Los Angeles
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Preclinical Development of a Novel Therapeutic for Parkinson’s Disease
Jane K. Osbourn · Alchemab Therapeutics
2024 · research · ASAP CRN Competitive Renewal Opportunity
IMPACT-PD: Implications of Polyamine and Glucosylceramide Transport in Parkinson’s Disease
Peter Vangheluwe · KU Leuven
2024 · research · Freezing of Gait Program
Use of Neuromodulation to Relieve Gait Freezing in Parkinson’s Disease
Ioannis Ugo Isaias · University of Würzburg
2024 · research · ASAP CRN Competitive Renewal Opportunity
Circuit Mechanisms for Dopamine Neuron Vulnerability and Resilience in Parkinson’s Disease
Nicole Calakos · Duke University
2024 · research · ASAP CRN Competitive Renewal Opportunity
Activation of Transposable Elements as a Trigger of Neuroinflammation in Parkinson’s Disease
Johan Jakobsson · Lund University
2024 · research · Alpha-Synuclein Post-Translational Modifications Quantification Program
Development of anAssay for Quantification of Alpha-synuclein and its Modifications
Judith A. Steen · Boston Children's Hospital
2024 · research · Research Grant
Generation of Induced Pluripotent Stem Cells with Indigenous Ancestry to Promote Inclusion of North America’s First Peoples in Parkinson’s Disease Research
Thomas M. Durcan · McGill University
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Examining the Effects of MTX325 on Mitochondrial Quality Control and the Prevention of Parkinson’s Disease Progression
Suhail Nurbhai · Mission Therapeutics
2024 · research · ASAP CRN Competitive Renewal Opportunity
Studying Basal Ganglia Networks in Parkinson's Disease
Peter L. Strick · University of Pittsburgh
2024 · research · iPSC Phenotyping Environmental Exposure Program
Establishing a Proof-of-concept, Automated Platform for Studying the Interactions of Genetic and Environment-based Toxicity in Human Cell Models of Parkinson’s Disease
Gist Croft · New York Stem Cell Foundation
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Using A Screening Platform Based on Induced-pluripotent Stem Cells to Study Parkinson’s Disease
Edward A. Fon · McGill University
2024 · research · ASAP CRN Competitive Renewal Opportunity
Studying the Pathogenesis of Parkinson’s Disease Via Single-cell Analysis of Human Brain and Gut Cells: A Basis for Clinical Translation
Thierry Voet · KU Leuven
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Evaluating the Role of CK1d Inhibition in Sleep Dysregulation and Alpha-synuclein Pathology in Preclinical Models of Parkinson’s Disease
Nicholas J. Brandon · Neumora Therapeutics
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Development of Brain-specific LRRK Inhibitors for Parkinson’s Disease
Nicholas T. Hertz · Montara Therapeutics, Inc.
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Alterations in DNA Repair Mechanisms in Parkinson’s Disease Neurons and their Correlation with Clinical Variables
Pier Giorgio Mastroberardino · University Of L'aquila, Erasmus Mc
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Targeting Lipid Biology in Stem Cell-derived Neurons to Develop a New Therapeutic Drug for Parkinson’s Disease
Richard Wade-Martins · University of Oxford
2024 · research · MJFF Funded Study
Epigenetic Analysis of Peripheral Immunity in Parkinson’s Disease
David Gate · Northwestern University
2024 · research · ASAP CRN Competitive Renewal Opportunity
Mapping the Modulatory Landscape Governing Dopamine-acetylcholine Signaling and its Dysregulation in Parkinson’s Disease
Stephanie Cragg · University of Oxford